orphan reach has been invited to present at the upcoming annual training event organized by the KSCD in Seoul, South Korea on 08 September 2016. The title of the presentation will be “Optimizing Global Clinical Development for Orphan Drugs”. Our CEO, Thomas Ogorka, commented that “it is an honour to be invited by the Korea Society for Clinical Development. I am hopeful that this event will give us the opportunity to learn from each other, so we can advance the global development of drugs for rare diseases together and accelerate their availability to patients.”

orphan reach is specialized in the conduct of clinical trials in rare diseases and has a track record of 143 clinical trials with orphan drugs. Whilst orphan reach is able to reach out to any country globally to recruit patients and execute trials locally, the operational model has been particularly designed to allow for lean management, optimized use of niche service providers, fast communication and cost effectiveness.